Munib Aftab, MD
Rheumatology · Morgantown, WVNPI 1962835074
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Amgen at 26.3% of the total. 2025 is the largest year on record at $1,003, more than ten times the $62 reported in 2021.
Across 154 payments — averaging $17.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$699
- AbbVie$478
- Johnson & Johnson$283
- UCB, Inc.$273
- Novartis$214
- Pfizer$153
- plus $564 from 11 others
What the payments were for
- Food & beverage$2,64399%
- Education$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 54 | $699 |
| AbbVie | 33 | $478 |
| Johnson & Johnson | 9 | $283 |
| UCB, Inc. | 11 | $273 |
| Novartis | 8 | $214 |
| Pfizer | 9 | $153 |
| GSK | 4 | $115 |
| Sobi, Inc | 6 | $108 |
| AstraZeneca(2 entities) | 5 | $106 |
| Boehringer Ingelheim | 4 | $66 |
| Janssen Scientific Affairs, LLC | 1 | $36 |
| Organon | 4 | $34 |
| Sandoz | 2 | $32 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Fresenius Kabi USA, LLC | 1 | $16 |
| Mallinckrodt Hospital Products Inc. | 1 | $13 |
How this compares
$2,663 in reported general payments places this provider in the 60th percentile of 26 rheumatology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 15 | $150,090 |
| Enbrel SureclickEtanercept | 16 | $115,448 |
| Orencia ClickjectAbatacept | 19 | $104,964 |
| Actemra ActpenTocilizumab | 19 | $83,391 |
| KevzaraSarilumab | 16 | $73,208 |
| Hydroxychloroquine Sulfate | 126 | $5,747 |
| MethotrexateMethotrexate Sodium | 141 | $3,754 |
| Colchicine | 54 | $2,038 |
| Prednisone | 220 | $1,946 |
| Sildenafil Citrate | 14 | $1,716 |
| Allopurinol | 84 | $1,045 |
| Duloxetine Hcl | 44 | $699 |
| Sulfasalazine DrSulfasalazine | 11 | $443 |
| Diclofenac Sodium | 29 | $373 |
| Celecoxib | 25 | $231 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Morgantown
- Brian HoustonMorgantown$10K
- Mandana HashefiMorgantown$1K
- Davisson WristonMorgantown$758
- Joann HornsbyMorgantown$682
- Jamie LatosMorgantown$352
- Matthew LivelyMorgantown$225
- Namitha NairMorgantown$79
- Colleen WatkinsMorgantown$0
- Wassim SaikaliBeckley$1.1M
- Suzanne GharibSouth Charleston$581K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.